title: Successful treatment of Aspergillus peritonitis in a peritoneal dialysis patient.
abstract: Aspergillus peritonitis is a rare, potentially fatal complication of continuous ambulatory peritoneal dialysis (CAPD). We report the successful treatment of refractory fungal peritonitis in an 8-year-old girl treated by peritoneal dialysis for 3.3 years. This is the second report of Aspergillus thermomutatus(telemorph: Neosartorya pseudofischeri) in humans. Comprehensive treatment included early removal of the CAPD catheter, the use of liposomal amphotericin B, and the use of itraconazole.
authors.affiliation: Department of Pediatrics, Saiseikai Kurihashi Hospital, 714-6 Kurihashi-cho Kitakatsushika-gun, Saitama 349-1105, Japan. naoko@pine.memail.jp
authors.forename: Naoko
authors.initials: N
authors.lastname: Matsumoto
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Shiraga
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Takahashi
authors.forename: Ken
authors.initials: K
authors.lastname: Kikuchi
authors.forename: Katsumi
authors.initials: K
authors.lastname: Ito
mesh_terms: D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001228:Aspergillosis / Q000209:etiology*; D002404:Catheterization; D002648:Child; D020878:Device Removal; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D017964:Itraconazole / Q000008:administration & dosage / Q000627:therapeutic use; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects* / Q000295:instrumentation; D010538:Peritonitis / Q000382:microbiology*
chemical_list: D000935:Antifungal Agents; D017964:Itraconazole; D000666:Amphotericin B